New Laboratory Tests and Services

MPDSP – Myeloproliferative Screening Panel, Next Generation Sequencing (NGS)

What is changing?

Effective Tuesday, July 14, BCR-ABL FISH Testing associated with test order MPDSP – Myeloproliferative Screening Panel, Next Generation Sequencing (NGS) will be brought in-house and tested by the Molecular Diagnostics Lab (GMC).

In the MPDSP order, BCR-ABL FISH testing will be replaced with BCR-ABL RT-PCR testing.

Current testing: When the procedure MPDSP is ordered, two tests are performed by the laboratory:

  1. FISH for BCR-ABL (referred test).
  2. MyGenVar Myeloproliferative Screening Panel, NGS (Molecular Diagnostics Lab)

Effective July 14 - When the procedure MPDSP is ordered, two tests are performed by the laboratory:

  1. BCR-ABL1 p190/p210, Diagnostic, RT-PCR (Molecular Diagnostics Lab) – BCRABD
  2. MyGenVar Myeloproliferative Screening Panel, NGS (Molecular Diagnostics Lab) – MPDSP

Novel Coronavirius COVID-19 Information

Changes to collection requirements for T4 T8 lymphocyte subset panel (T4T8), CD4P T-cell subset panel(CD4P), and CID related subsets(SCIDF)

Effective February 26, 2020, specimen requirements for these have changed: The required specimen is two EDTA lavendar-top tubes, rather than one EDTA lavender-top tube and one sodium heparin tube. Do not combine the EDTA lavender-top tubes.

If you have any questions, please call 1-800-695-6491 or refer to our test catalog for additional information.

Locations  |    Search  |    Site Map |   Contact Us

©2000-2021 Geisinger Health System.   All rights reserved.